Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Management of Retinitis Pigmentosa by Wharton's Jelly Derived Mesenchymal Stem Cells: Preliminary Clinical Results

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04224207
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:27.507614+00:00
Published At
2020-01-13T00:00:00+00:00
Record Updated At
2020-01-13
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Retinitis Pigmentosa", "Inherited Retinal Dystrophy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-01-13"
protocolSection.identificationModule.nctId
"NCT04224207"
protocolSection.identificationModule.officialTitle
"Management of Retinitis Pigmentosa by Wharton\u0027s Jelly Derived Mesenchymal Stem Cells: Preliminary Clinical Results"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Retinitis Pigmentosa (protocolSection.conditionsModule.conditions)
  • Inherited Retinal Dystrophy (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.